Suvretta Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $67.2M | Buy |
|
|||||
|
2023
Q1 | $36.3M | Buy |
|
|||||
|
2022
Q4 | $37.9M | Buy |
|
|||||
|
2022
Q3 | $27.3M | Sell |
|
|||||
|
2022
Q2 | $31.2M | Buy |
|
|||||
|
2022
Q1 | $23.5M | Buy |
|
|||||
|
2021
Q4 | $20.3M | Buy |
|
|||||
|
2021
Q3 | $13.4M | Buy |
|
|||||
|
2021
Q2 | $13.7M | Buy |
|
|||||
|
2021
Q1 | $8.54M | Buy |
|
|||||
|
2020
Q4 | $8.35M | Buy |
|
|||||
|
2020
Q3 | $2.77M | Buy |
|
|||||
|
2020
Q2 | $1.85M | Buy |
|